SARS-CoV-2 patient samples

PM Patrick J. Macdonald
JS Jeffrey M. Schaub
QR Qiaoqiao Ruan
CW Carroll L. Williams
JP John C. Prostko
ST Sergey Y. Tetin
ask Ask a question
Favorite

Serum samples from random, unidentified individuals who received either two doses of the Pfizer/BioNTech vaccine, one dose of the Johnson & Johnson/Janssen vaccine, or two doses of the Moderna vaccine were purchased from Access Biologicals, LLC (Vista, CA). Additional Pfizer and Johnson & Johnson vaccine panels were purchased from Precision for Medicine (Norton, MA). For each vaccine panel, the serum samples used in this study were drawn approximately 35–60 days after the individual received their first dose of vaccine. Total numbers of patients measured in this study were as follows: Pfizer: 26 individuals, Moderna: 29 individuals, and J&J: 19 individuals. Six additional patients were not included in this study as they were deemed not measurable due to very low antibodies or very high background (Pfizer: 3, Moderna: 1, J&J: 2).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A